Abstract
Several studies have identified FcgRIIIb (Fcgr3b) polymorphisms that determine susceptibility to autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. The objective of the study was to clarify whether Fcgr3b allele polymorphism influence susceptibility to immunoglobulin A nephropathy (IgAN), clinical features or severity in patients with IgAN. Deoxyribonucleic acid (DNA) fragments were amplified by polymerase chain reaction (PCR) using genomic DNA from 172 unrelated, healthy blood donors and 128 IgAN patients in our Kidney Disease Centre. The present findings showed that Fcgr3b genotype influenced the disease susceptibility and severity of IgAN, although Fcgr3b polymorphism did not affect the age of the disease onset. We found that the genotype frequency of Fcgr3b heterozygote NA1/NA2 in IgAN patients in Chinese significantly higher than that of healthy donors. Furthermore, higher genotype frequency of NA1/NA2 was found also in IgAN patients with glomerulosclerosis or crescent formation than those without it. NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese. J. Clin. Lab. Anal. 21:298–302, 2007. © 2007 Wiley‐Liss, Inc.
Keywords: Fc gamma receptor, polymorphism, IgA nephropathy
REFERENCES
- 1. Parren PWHI, Warmerdam PAM, Boeije LCM. On the interaction of IgG subclasses with the low affinity FcgR IIa (CD32) on human monocytes, neutrophils, and platelets: analysis of a functional polymorphism to human IgG2. J Clin Invest 1992;90:1537–1546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcg receptor IIA and Fcg receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992;89:1274–1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003;61:189–202. [DOI] [PubMed] [Google Scholar]
- 4. Bredius RG, Fijen CA, De Haas M. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1 and IgG3‐opsonized bacteria and erythrocytes. Immunology 1994;83:624–630. [PMC free article] [PubMed] [Google Scholar]
- 5. Hatta Y. Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA, polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1999;1:53–60. [DOI] [PubMed] [Google Scholar]
- 6. Hotta O, Yusa N, Ooyama M, Unno K, Furuta T, Taguma Y. Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int 1999;55:1927–1934. [DOI] [PubMed] [Google Scholar]
- 7. Bux J, Stein EL, Santoso S, Mueller‐Eckhardt C. NA gene frequencies in the German population determined by polymerase chain reaction with sequence‐specific primers. Transfusion 1995;35:54. [DOI] [PubMed] [Google Scholar]
- 8. Steffensen R, Gülen T, Varming K, Jersild C. FcgRIIIb polymorphism: evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population. Transfusion 1999;39:593–598. [DOI] [PubMed] [Google Scholar]
- 9. Lee SMK, Rao VM, Franklin WA. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982;13:314–322. [DOI] [PubMed] [Google Scholar]
- 10. Ravetch JV. Fc receptors: rubor redux. Cell 1994;78:553–560. [DOI] [PubMed] [Google Scholar]
- 11. Rascu A, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG. Clinical relevance of Fc gamma receptor polymorphisms. Ann NY Acad Sci 1997;815:282–295. [DOI] [PubMed] [Google Scholar]
- 12. Ozturk C, Aksu G, Berdeli A, Kutukculer N. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases. Clin Exp Med 2006;6:27–32. [DOI] [PubMed] [Google Scholar]
- 13. Takai T. Roles of Fc receptors in autoimmunity. Nature Rev Immunol 2002;2:580–592. [DOI] [PubMed] [Google Scholar]
- 14. Coppo R, Basolo B, Martina G. Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch‐Schoenlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 1982;18:230–239. [PubMed] [Google Scholar]
- 15. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis 1998;31:962–970. [DOI] [PubMed] [Google Scholar]
- 16. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutrophil FcgRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403–2413. [PubMed] [Google Scholar]
- 17. Huizinga TWJ, Kuijpers RW, Kleijer M, Schulpen TW, Cuypers HT, Roos D, von dem Borne AE. Maternal genomic neutrophil FcgRIII deficiency leading to neonatal isoimmune neutropenia. Blood 1990;76:1927–1932. [PubMed] [Google Scholar]
- 18. Tong Y, Jin J, Yan LX, Neppert J, Marget M, Flesch BK. FCGR3B gene frequencies and FCGR3 variants in a Chinese population from Zhejiang Province. Ann Hematol 2003;82:574–578. [DOI] [PubMed] [Google Scholar]
- 19. Amigorena S, Bonnerot C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol Rev 1999;172:279–284. [DOI] [PubMed] [Google Scholar]